Prothena
Shailaja Korukonda is an accomplished professional with extensive experience in the pharmaceutical industry. Currently serving as Vice President at Prothena Corporation plc, Shailaja has previously held key positions including Executive Director - Launch Lead at Shionogi Inc. and Executive Director - Global Commercial Lead for Alzheimer’s Disease Assets at Eisai US. Shailaja also served as U.S. Senior Director and Commercial Lead for Acthar at Mallinckrodt Pharmaceuticals, demonstrating a strong track record in leadership and commercial strategy within the sector.
This person is not in any teams
This person is not in any offices
Prothena
Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies with the potential to fundamentally change the course of devastating neurological disorders.